Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice-Reference-Cited by-同舟云学术

Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice

Published:2006-02 Issue:7 Volume:24 Page:989-996
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hartley Gill,Taylor Rosa,Prior Jo,Newstead Sarah,Hitchen Paul G.,Morris Howard R.,Dell Anne,Titball Richard W.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference25 articles.

1. Tularemia;Ellis;Clin Microbiol Rev,2002

2. Nature of protective immunity to Francisella tularensis;Tarnvik;Rev Infect Dis,1989

3. Soviet viable Pasteurella tularensis vaccines;Tigertt;Bact Revs,1962

4. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in the prevention of laboratory-acquired tularemia;Burke;J Infect Dis,1977

5. The tularemia vaccine;Sandstrom;J Chem Tech Biotechnol,1994

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation of wbtJ, a N-formyltransferase involved in O-antigen synthesis, results in biofilm formation, phase variation and attenuation in Francisella tularensis;Microbiology;2024-02-29

2. Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in healthy research laboratory workers;Frontiers in Bacteriology;2024-01-03

3. Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories;2023-01-11

4. Why vary what’s working? Phase variation and biofilm formation in Francisella tularensis;Frontiers in Microbiology;2022-12-06

5. Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle;PLOS ONE;2022-03-11